Ann: Notice of Investor Call and Presentation, page-138

Agree, but still inclined to think that we can do both at the same time. Prove the IIH thesis and at the same time pursue another indication with surplus funds. On a superficial level, another indication means SP momentum with more news flow/announcements, potential for unexpected positive news, and means the wider may take notice/care. On a deeper level, it means a larger portfolio which equates to less risk, and most importantly, it makes things more attractive to potential buyers. Of course, all IMO.

And on another note, I don't think the market has priced in 1 trial to satisfy the EMA. At current SP levels, it seems more likely that the market has priced in two trials with additional funds needed/share dilution. I saw this comment somewhere above.